XP03 |
NSC-226516 |
METHOTRIMEPRAZINE |
NIRVAN |
CL-39743 |
XP-03 |
N05AA02 |
LEVOMEPROMAZINE |
SK&F-5116 |
TISERCIN |
CL-36467 |
RP-7044 |
LEVOPROME |
NOSINAN® |
LEVOMEPROMAZINUM |
(-)-10-(3-(DIMETHYLAMINO)-2-METHYLPROPYL)-2-METHOXYPHENOTHIAZINE |
LEVOPROME® |
NOZINAN® |
(-)-(2R)-3-(2-METHOXY-10H-PHENOTHIAZIN-10-YL)-N,N,2-TRIMETHYLPROPAN-1-AMINE |
LEVOMEPROMAZINA |
2-METHOXYTRIMEPRAZINE |
rxcui:6852 |
chembl:CHEMBL1764 |
pubchem.compound:72287 |
chemidplus:60-99-1 |
drugbank:01403 |
Year of Approval | not approved by the fda |
Drug Class | antipsychotic agents |
FDA Approval | not approved by the FDA |
Drug Class | small molecule |
Drug Indications | Antipsychotic Agents |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
n/a |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
antagonist (inhibitory) |
Novel drug target | Established target |
Trial Name | - |
antagonist (inhibitory) |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Mechanism of Interaction | D2-like dopamine receptor antagonist |
Direct Interaction | yes |
antagonist (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
METHOTRIMEPRAZINE | Primary Drug Name |
Drug Class | antipsychotic agents |
Year of Approval | not approved by the fda |
Drug Indications | Antipsychotic Agents |
Drug Class | small molecule |
FDA Approval | not approved by the FDA |
D09LZT | TTD Drug ID |